Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Salona Global Medical Device Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/17/2023 |
8-K
| Quarterly results|
Docs:
|
"Loan and Security Agreement, between Simbex, Mio-Guard and Damar and Pathward, National Association",
"Guaranty, by the Company",
"Salona Global Announces Third Quarter Results, Posts 211% Year-Over-Year Revenue Growth, 231% in Gross Margin Growth, Improved Gross Margin to 33%; Shifts Focus to Higher Margin Revenue Lines SAN DIEGO, January 17, 2023 - Salona Global Medical Device Corporation today announced highlights for the third fiscal quarter of 2023, ending November 30, 2022. The Company posted 211% year-over-year revenue growth, 231% year-over-year gross margin growth, and improved gross margin as a percentage of revenue by 10% over last quarter to 33%. The Company also provided an update on the progress toward closing the recently announced acquisition and its focus to list on a US stock exchange. Salona Global in its current form listed in June 2021 on the TSX Venture Exchange with a plan to become a leading m..." |
|
| 10/17/2022 |
8-K
| Quarterly results|
Docs:
|
"Salona Global Announces Second Quarter Results, Posts 153% Year-Over-Year Revenue Growth, 152% in Gross Profit Growth; Builds $18.5M Order Book Backlog SAN DIEGO, October 17, 2022 -- Salona Global Medical Device Corporation today announced highlights for the second fiscal quarter of 2023, ending August 31, 2022. Financial statements for the quarter will be posted today post market closing. Additionally, the Company reported a record order book backlog of $18,500,000 across all its subsidiaries. Financial and Business Headlines Revenues 153% year-over-year growth in revenues, building quarterly revenues to $10,044,239, as compared to $3,973,773 for the same quarter in the prior year. 300% year-over-year increase in total cash receipts for the second quarter, taking in approximately $13.6 m..." |
|
|
|